Future - Proof Patent Claims in Settled Technology Collaborations : Drafting for Ownership, Innovation, and Prosecution of Patents

Introduction : Innovation today almost never results from independent research. Regardless of whether it relates to the production of drugs, AI, semiconductors, biotech, or software development, innovations today are the result of collaboration between companies, scientific organizations, universities, and startups. While collaboration expedites innovation because of the sharing of technical expertise and funds, it adds complexity to the management of intellectual property rights. The problem with contemporary patent cases does not lie in that they do not have an immediate solution via judicial ruling or licensing; rather, it lies in the fact that the solution often comes in the form of a sustained commercial relationship in which both parties will further innovate technology together.

The importance of this problem has increased from a business perspective since the value of future inventions can exceed the value of the original patented invention. Research in collaboration will definitely result in improvements, innovations, optimization of processes, upgrading of software, and creation of new uses which might not have been anticipated at the time the agreement was signed. The lack of well-thought-out contract terms for the future patents leads to inevitable disputes over the issues of inventorship, ownership, patenting, licensing, and commercialization of the patents. These disputes not only negate the commercial intent of the agreement but also lead to litigation.

Indian patent law provides very little in terms of statutory guidelines for distribution of rights with respect to inventions resulting from any collaborative venture. The Patents Act, 1970, which takes note of assignment, licensing and co-ownership of patents, lacks any statutory guidelines for managing future inventions which may be made post entering into the settlement or collaboration agreement. The onus thus falls on the parties concerned to rely on contract drafting for allocation of rights and exploitation of improvements. This also means that the parties have an obligation to foresee any future development in technology at a much later stage.

Conversely, jurisdictions such as the United States and the United Kingdom have been characterized by judicial deliberation in matters of collaborative research in respect to assignment provisions, employee inventions, and joint intellectual property rights development. Practices in Europe and Japan are no different and also reveal the same predilection towards contractual regulation of matters, bearing in mind that statutory provisions do not always satisfy business realities. Comparative experience in all jurisdictions is based on one universal principle: innovation must always form an essential part of any technology arrangement.

The article considers how agreements involving settlement and cooperation in technology need to regulate future patent claims through appropriate provisions pertaining to rights reservations, ownership of developments, control over patent prosecution and scope of the contract. This paper will consider comparative approaches taken in India, the USA, UK, European patents and Japan to show how careful drafting can reduce uncertainties and promote innovation. Finally, the paper attempts to prove that the success of technology collaboration is based not only on the solution of disputes that have already occurred but also on governing innovations that collaboration may bring about in the future.

Ownership of Future Inventions - The Main Problem in Technology Collaborations

Probably the most disputable problem in the context of technology collaborations relates to the ownership of inventions made after the signing of the agreement between the parties. While great effort is being made by parties to settle problems regarding existing patents, little attention is paid to the allocation of rights for future inventions that can be made as a result of collaboration. This is where the main problem occurs because any collaboration is characterized by constant development. Technologists, engineers, software specialists, researchers constantly develop existing technologies, optimize manufacturing processes, improve algorithms and invent new products that nobody could have even guessed about at the moment of settlement.

While tangible assets are not normally dynamic, technological advancements are not usually stagnant. For example, a chemical substance protected by a pharmaceutical patent may later undergo changes to increase its bioavailability; a machine learning algorithm may undergo further training with better data sets; a semiconductor design may continuously get optimized; and software used within enterprises may regularly undergo updates to add new features, which significantly improve its market value. Any one of the above innovations can be novel enough to qualify for a patent on grounds of novelty, inventive step, and industrial application. Without prior contractual arrangements, disputes over ownership and inventorship are bound to occur.

Typical commercial practice will follow any of the following four ownership models. In the first model, ownership of inventions independently conceived and developed by employees of either party is exclusively retained by each party respectively. Even though the method may be simple from an administration point of view, it creates difficulties in situations where the inventions arise from true collaborative research which entails employees from various firms.

The second model assigns ownership based on inventorship, in that the party whose employees meet the requirements for inventorship as stipulated under the particular patent laws shall hold the patent right. Though legally valid, the method often calls for intensive investigations of facts and technical evidence in identifying inventiveness of individuals. Ownership may also be based on the financial investment made in the collaborative research by one party on behalf of another. Alternatively, the parties may decide to own jointly all the inventions created in the course of the collaboration regardless of inventorship.

Whereas joint ownership seems economically fair, practical experience in various jurisdictions has shown that it often causes more problems than solutions. The co-owners can differ about the strategy for licensing, enforcement, filing overseas, negotiating an infringement, and royalty distribution. The lack of contractual provisions on such matters makes many joint patents economically unexploited despite their importance technologically. Therefore, complex contracts make hybrid forms of ownership more common today where ownership is determined by inventorship, but the non-owner gets negotiated license rights.

It is important to note that the importance of proper language in assignments was clearly stated by the United States Supreme Court in Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc., where the issue involved who had the ownership rights for inventions made through federally funded research collaborations. The Supreme Court ruled that the ownership of patent would depend on how the language in the assignments was drafted, and this involved the difference between the promise to assign inventions in the future and actual assignment of inventions at present. This decision changed how research collaborations were carried out, showing that there could be differences between ownership based on slight variations in drafting language.

Likewise, the judgment of the United States Court of Appeals for the Federal Circuit in Ethicon, Inc. v. United States Surgical Corp. reflects some of the practical difficulties arising from the joint ownership of patents. As noted by the Court, "under U.S. patent law, each co-owner has the independent right to use the patented invention without compensating the other co-owner and without being subject to an action for infringement without joining all the co-owners." While these principles may be jurisdiction-specific, they reflect the commercial uncertainty created by lack of clarity regarding ownership structure during the contract-making phase. Consequently, organizations entering into business collaborations have been increasingly turning to contracts to address these issues.

In essence, the Indian approach is different from the above discussed approach in a number of aspects, but arrives at the same practical solution. Despite the fact that the Indian Patents Act, 1970 provides for joint ownership and assignment/licensing of the patent, it does not provide an elaborate statutory scheme for the exercise of the rights of co-owners akin to what is seen through contractual practice in the USA or Europe. Therefore, it is not safe for Indian parties to enter into any technology collaboration on the basis of any statutory provision.

Another set of innovation-driven jurisdictions has applied similar contract-based approaches. For instance, in the United Kingdom, collaborative research contracts usually distinguish between background intellectual property and created intellectual property as well as determine ownership according to inventorship unless another agreement is made. In turn, the European Patent Convention, which gives a single process of obtaining European patents, explicitly does not regulate ownership and thus confirms the importance of contractual approach to ownership among collaborators.

Technology collaboration in Japan also involves contract management, particularly in those cases when there is collaboration between universities and industries and when the government guidelines recommend reaching an agreement on the issues of ownership, commercialization, confidentiality, and sharing of profits before conducting any research. Thus, from all these jurisdictions it becomes clear that the lesson learned is absolutely obvious: patent law sets the grounds of patentability statutorily, while commercial ownership is based on contract drafting.

With the ever-growing use of artificial intelligence in research, this scenario becomes even more complicated. Machines can help in the discovery of molecular structure, in optimizing engineering designs, coding software programs, and solving technological problems. While present-day patent legislation still allows recognition of only human inventors, the question regarding the degree of human inventive input in inventions with the help of AI will be becoming increasingly hard to answer. The settlement agreements signed today need to account for future developments in the field of technology by specifying the ownership of AI-based inventions, of datasets used during collaboration, as well as improvements to algorithms and machine-produced output.

Considering them together, comparative practices show that ownership clauses must not only specify the owner of any subsequent patent rights. They must define an integrated system of governance based on inventorship, business goals, licensing rights, enforcement rights, and technology development. Those who ignore all of this risk finding that what they think is their least valuable disagreement turns out to be their most valuable creation.

Patent Prosecution Control and Scope Limitations – Avoiding Future Disputes by Way of Strategic Drafting

Intellectual property management with respect to collaborative technologies involves not only the issue of ownership of the patent but also the matter of who manages the patent prosecution process. Patent prosecution refers to all the stages involved in the process of obtaining a patent, including assessment of patentability, claim drafting, responding to examination reports, amendment of specifications, filing of divisional or continuing applications, filing of foreign patents, paying maintenance costs for patents, and defense of granted patents against opposition or revocation. The decision made during the process of prosecution will impact the scope, enforceability, and commercial potential of the obtained patent.

This problem is even more critical in collaborative research since the business considerations of the collaborating organizations are rarely aligned. While the technology developer might want broad claims for patents in order to increase the number of opportunities for license agreement, the manufacturing organization would like narrow claims which would protect only the product but would not attract any opposition or detailed review. At the same time, one collaborator will be interested in filing patents under the international regime of PCT, while the other will think that it is not commercially justified because of lack of funds.

For these reasons, complex technology contracts very seldom depend on joint decision-making in any unqualified way. In such contracts, there is usually a lead prosecution entity assigned to deal with all contacts with patent offices while at the same time the agreement imposes the obligation to discuss all decisions which have significant influence on patent scope or its enforcement with the other partner. This approach allows us to reconcile convenience and responsibility. Common practice includes the requirement to inform the collaborating party about all drafts of patent specifications, answers, claims amendment proposals and foreign filing decisions.

Cost sharing is yet another important element of prosecution control. International patent prosecution has become extremely costly, especially when one seeks parallel prosecution at the Indian Patent Office, USPTO, EPO, JPO, and national patent offices of other countries. The agreements should, hence, clarify which side is responsible for the cost related to drafting, filing, translating, examining, maintaining, and enforcing patents. Additionally, the agreements should discuss the situation whereby one side opts not to engage in foreign prosecution. A common approach in business is for the remaining partner to take over the prosecution on its own but enjoy greater rights in such countries. This avoids abandonment of valuable patent applications simply because of differences in commercial considerations between the partners.

The practice of comparative analysis reveals that the governance of prosecution is mainly contractually rather than statutorily driven. According to the Indian patent law, there are certain procedural standards set regarding the examination and grant of patents, but the commercial allocation of prosecution rights remains private. The same applies to the European Patent Convention according to which there is an established harmonized examination process within the European Patent Office but no regulations concerning ownership or decision-making between joint applicants. In the US, high-tech collaborations always establish a patent management committee made up of delegates from each collaborator for the management of prosecution policy, evaluation of continuation applications and enforcement priorities. In Japan, joint research contracts are also characterized by regular meetings for technical reviews, as prosecution rights need to change along with technologies rather than stay fixed at the very beginning of the collaboration.

Linked directly to prosecutory control is the issue of clearly defining the rights being granted under the collaboration agreement. Technology contracts often go awry because they define the intellectual property rights granted in overly broad terms. An authorization allowing the use of patented technology for commercial purposes offers no direction at all on whether or not the licensee is allowed to make derivatives, work in other market spaces, license the technology further, or use it outside the particular industry altogether. This ambiguity is especially troublesome when the research leads to inventions beyond the initial commercial application.

Therefore, scope limitations are becoming more common in contemporary technology agreements. Field-of-use limitations refer to the specific industrial or technological fields in which the licensed technology can be exploited. For instance, a patented technology can be licensed only for use in the veterinary field and not for human medicinal applications, which would be retained by the patent holder. Territorial limitations pertain to the regions in which exploitation of the licensed technology will take place in order to avoid unwanted competition in strategic markets. Scope limitations based on application differentiate between research activities and manufacturing activities to ensure that exploitation for research purposes does not grant automatic rights for commercial exploitation.

This issue is especially important in emerging industries like artificial intelligence, cloud computing, biotechnology, and advanced manufacturing, where a technology platform may be used in multiple distinct commercial applications. AI algorithms created initially for medical diagnostics may later find applications in the financial industry, information security, or self-driving vehicles. If cooperation agreements do not specify the extent of allowed use, it is very likely that conflicts regarding the application of the invention in other industries will arise. Thus, in order to guarantee commercial certainty, it is necessary to expect technology convergence in the future.

Collaborations that involve intensive technological engagement must be accompanied by a full drafting that goes far beyond standard clauses about patent assignments. The agreements must provide for the definition of background IP, foreground IP, improvements, derivative inventions, confidential information, data sets, algorithm updates, and trade secrets. They must also provide for mandatory disclosure protocols where researchers must submit their reports on potentially patentable inventions within certain time frames, followed by evaluation by a joint patent committee that decides on inventorship, ownership, and filing approach. Ownership matrices that specify the approach to inventions developed independently, jointly, improved inventions, and those developed with the help of artificial intelligence greatly minimize future uncertainty.

Of equal significance are terms relating to confidentiality, publication, and data management. Collaboration can involve academic institutions or research laboratories that have different aims of publications from those necessary for patent protection. This necessitates the need for agreements that include an obligation to review articles submitted for journal publication, conferences, technical disclosure, and open-source software before any premature publication that would render the patents invalid because of public disclosure. Likewise, cybersecurity measures and data management policies need to be included in the overall intellectual property policy, especially if artificial intelligence systems depend on collaborative data sets.

Conclusion

Collaborations on technology are no longer limited to the trade in existing intellectual property but rather are innovation ecosystems that continue to produce commercially revolutionary technology well beyond the completion of the settlement agreement. Within such an ecosystem, the settlement agreement must no longer be seen simply as a tool for sorting out past grievances but rather as a form of governance for the management of ownership, protection, enforcement, and commercialization of future technology. Those who deal with the agreement solely in terms of their present grievances tend to forget that their most important intellectual property is yet to come into being.

It should be noted that comparative analysis shows that no leading jurisdiction regarding innovations uses only statutory patent law for regulating collaboration innovation. In India, the USA, the UK, Europe, and Japan, commercial certainty is achieved mainly by using highly developed contractual arrangements which consider future needs rather than solve arising problems after disputes have occurred. Reserve rights clauses guarantee the protection of the current intellectual property; ownership clauses distribute rights in respect of future inventions; prosecution control clauses provide an effective patent policy; and scope limitations help to avoid disputes over commercial utilization. All these clauses make settlements not a remedy but a tool for fostering innovation. With the rise of AI in collaborative research, cross-border data transfer, advanced manufacturing, and technological development in various industries, the current approach to drafting will no longer suffice.

As such, the next agreement should cover issues of conventional patent ownership as well as new issues in relation to inventions using AI, improvements to algorithms, digital property, data sets, and commercial applications that change at a fast pace. What matters most when it comes to a successful collaboration is not so much the conflict that was settled, but rather the ability of the agreement to control the innovations that will make up the market of the future. With intellectual property being one of the key commercial assets in the modern economy, the best collaborations will be those that anticipate future patents rather than see them as unexpected events.

Author :- Gowri V S, in case of any query, contact us at Global Patent Filing or write back us via email at support@globalpatentfiling.com.

End Notes

1. The Patents Act, No. 39 of 1970, §§ 6, 48, 50, 68 (India).
2. Agreement on Trade-Related Aspects of Intellectual Property Rights arts. 27–34, Apr. 15, 1994, Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, 1869 U.N.T.S. 299.
3. Patent Cooperation Treaty arts. 3–11, June 19, 1970, 1160 U.N.T.S. 231.
4. Novartis AG v. Union of India, (2013) 6 SCC 1.
5. Enercon (India) Ltd. v. Aloys Wobben, (2014) 5 SCC 1.
6. Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc., 563 U.S. 776 (2011).
7. Ethicon, Inc. v. United States Surgical Corp., 135 F.3d 1456 (Fed. Cir. 1998).
8. Thaler v. Vidal, 43 F.4th 1207 (Fed. Cir. 2022).
9. Office of the Controller General of Patents, Designs and Trade Marks, Manual of Patent Office Practice and Procedure (Version 3.0, 2019).
10. United States Patent and Trademark Office, Manual of Patent Examining Procedure (10th ed., Rev. 07.2022, Feb. 2023).
11. European Patent Office, Guidelines for Examination in the European Patent Office (2025 ed.).
12. Japan Patent Office, Examination Guidelines for Patent and Utility Model (latest revision).
13. World Intellectual Property Organization, Patent Drafting Manual (2d ed. 2023).
14. World Intellectual Property Organization, Successful Technology Licensing (2d ed. 2015).
15. Donald S. Chisum, Chisum on Patents (LexisNexis, latest update).